Nevada
Nevada
In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.
In Your State
Economic Impact In Your State: Nevada
Economic Impact
$5.5B
Total output supported by biopharmaceutical sector
$334.8M
Tax Revenue Generated
19,268
Total Jobs
3,718
Direct Jobs
418
Total Clinical Trials
$138.9 million
Invested in Clinical Trials
8,189
Total Economic Impact of Clinical Trial Investments
$357.1 million
Invested in Clinical Trials
Programs and Initiatives in Your State: Nevada
State programs and initiatives to promote biopharmaceutical industry development
- Accelerating Innovation, Commercialization & Entrepreneurial Development
- Building Research Capacity and/or R&D Infrastructure
- Economic Innovation Incentives
- STEM Education & Workforce Development
- Venture Financing